QGEN (Qiagen NV) Gross Sales Margin

Official company branding of Qiagen Group (QGEN)

The implementation of recyclable plastics in test packaging reduces costs, and the gross profit margin on GURU.Markets highlights this trend, where the 62.40 metric confirms the current level. The Qiagen N.V. (QGEN) model is based on the expansion of instrument placement to drive sales of high-margin reagents, while growth is supported by the targeted acquisition of bioinformatics services to enhance core DNA analysis systems.

Gross Profitability: Qiagen NV (QGEN) for 07/04/2022 - 11/20/2026

Analytical breakdowns and data insights for company Qiagen (QGEN)

- market price and analyst price targets:
- business market valuation indicators:
Fundamental valuation:Qiagen N.V.
Brand item of qiagen.com

The market values Qiagen N.V. (QGEN) as a technologically resilient asset with high scalability potential. Gross margin measures the profit share after deducting direct production costs, reflecting the efficiency of cost-of-goods-sold management. By analyzing the current gross margin level, an investor can see the returns from the robotization of DNA and RNA analysis processes. This metric confirms the security's status as a high-margin technological production.

Main competitors

Return on Gross Profit Tempus AI Inc|IONS (Isis Pharmaceuticals) - Gross Margin|Repligen Inc. - Gross Profitability Margin|Gross Margin RNA|CRSP - Gross Profit Margin|GeneDx - Return on Gross Profit|Gross Profit Rate RARE|Beam Tx - Gross Margin|SRPT - Gross Margin|TWST (Twist Bio) - Return on Gross Profit|Gross Return on Sales TXG|Return on Gross Profit NTLA|Stoke Therapeutics Inc (STOK) - Return on Sales by Gross Profit|Gross Margin BLFS|Gross Profitability WVE (Wave Life Sciences Corp)|Gross Profitability Maze Therapeutics MAZE|Gross Profit Rate SION|PRME - Gross Profitability|Return on Sales by Gross Profit Taysha TSHA|QURE: Gross Margin|Return on Gross Profit MeiraGTx PLC|RGNX (REGENXBIO Inc) - Gross Margin|solidbio.com (SLDB) - Return on Sales by Gross Profit|Gross Profitability Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Gross Return on Sales|Benitec Biopharma - Return on Gross Profit|DSGN: Gross Return on Sales|RCKT: Return on Gross Profit|FDMT - Gross Margin|LXEO: Gross Margin|Korro Bio Inc. - Gross Profit Rate|EDIT (editasmedicine.com) - Gross Margin|Gross Profitability SLN|Gross Profitability ProQR Therapeutics NV (PRQR)|Codexis - Gross Return on Sales|Gross Profitability Sangamo SGMO|NAUT: Gross Return on Sales|MGX: Return on Gross Profit|Gross Profit Margin Precision BioSciences|GBIO (generationbio.com) - Return on Gross Profit|Gross Profit Margin boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Gross Margin|Gross Return on Sales IMNN (Imunon, Inc.)|Gross Margin PHIO|MBIO - Gross Profit Margin|Gross Margin RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Gross Profit Margin|Applied DNA - Gross Margin|Gross Profit Margin Bluebird Bio|ImmunoPrecise (IPA) - Gross Profitability|Gross Profitability Margin OMGA (Omega)|Gross Profitability Singular Genomics Systems|Gross Profit Margin regulusrx.com RGLS|Gross Profitability Syros Pharmaceuticals Inc. (SYRS)|Return on Sales by Gross Profit Codex DNA|Gross Profitability TRACON TCON|Unity Biotechnology, Inc - Gross Profitability